Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Head & Neck 2Gynecologic 2Gastrointestinal 2Endocrine 2Dermatologic 2Thoracic 1Other solid neoplasm 1Genitourinary 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 916Lung Neoplasms 621Small Cell Lung Carcinoma 170Colorectal Neoplasms 133Melanoma 109Breast Neoplasms 107Neoplasms 98Ovarian Neoplasms 94Neoplasm Metastasis 90Pancreatic Neoplasms 76Squamous Cell Carcinoma of Head and Neck 70Stomach Neoplasms 60Carcinoma, Renal Cell 58Head and Neck Neoplasms 55Esophageal Neoplasms 51Endometrial Neoplasms 51Triple Negative Breast Neoplasms 50Prostatic Neoplasms 47Uterine Cervical Neoplasms 44Colonic Neoplasms 42Urinary Bladder Neoplasms 41Mesothelioma 40Carcinoma, Hepatocellular 38Mesothelioma, Malignant 37Brain Neoplasms 34Sarcoma 29Carcinoma, Transitional Cell 29Adenocarcinoma of Lung 28Lung Diseases 26Disease 26

Interventions

atezolizumab 1Immunoglobulin G 1Disulfides 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma, Mucinous × Thoracic × 90 days × Clear all
NCT03074513 2026-03-11

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
133 enrolled
DermatologicEndocrineHead & NeckOther solid neoplasmThoracic

Nasopharyngeal Carcinoma, Mesothelioma, Malignant, Adenocarcinoma, Mucinous, Adenoma, Islet Cell, Nasopharyngeal Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡